Atypical teratoid rhabdoid tumor other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
Line 10: Line 10:


===Fluorescent In Situ Hybridization===
===Fluorescent In Situ Hybridization===
[[Cytogenetics]] is the study of the tumor’s genetic make-up.  A technique called [[Fluorescent in situ hybridization|fluoresecene in situ hybridization (FISH)]] has been gaining attention in the literature because it may be able to help locate a mutation or abnormality that may be allowing tumor growth.  Also, this technique has been shown to be useful in identifying some tumors and distinguishing two histologically similar tumors from each other (such as AT/RTs and PNETs). In particular, medulloblastmas/PNETs may possibly be differentiated cytogenetically from AT/RTs as chromosomal deletions of 17p are relatively common with medulloblastoma and abnormalities of [[22q11.2 deletion syndrome|22q11.2]] are not seen.  On the other hand, chromosomal 22 deletions are very comomon in AT/RTs.
*Fluorescence in situ hybridization demonstrates abnormalities of [[22q11.2 deletion syndrome|chromosome 22q11.2]].
 
In importance of the [[SWI/SNF|hSNF5/INI1]] gene located on chromosomal band [[22q11.2 deletion syndrome|22q11.2]] is highlighted in the summary paper form the Workshop on Childhood Atypical Teratoid Rhabdoid Tumors as the mutation’s presence is sufficient to change the diagnosis from a medulloblastoma or PNET to the more aggressive AT/RT classification. However, it should be noted that this mutation is not present in 100% of cases.  Therefore, if the mutation is not present in an otherwise classic AT/RT immunohistochemical and morphologic pattern then the diagnosis remains an AT/RT.


===Bone Marrow Aspiration===  
===Bone Marrow Aspiration===  

Revision as of 21:03, 16 December 2015

Atypical teratoid rhabdoid tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Atypical Teratoid Rhabdoid Tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Atypical teratoid rhabdoid tumor other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Atypical teratoid rhabdoid tumor other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atypical teratoid rhabdoid tumor other diagnostic studies

CDC on Atypical teratoid rhabdoid tumor other diagnostic studies

Atypical teratoid rhabdoid tumor other diagnostic studies in the news

Blogs on Atypical teratoid rhabdoid tumor other diagnostic studies

Directions to Hospitals Treating Atypical teratoid rhabdoid tumor

Risk calculators and risk factors for Atypical teratoid rhabdoid tumor other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Other Diagnostic Studies

Biopsy

Biopsy is performed for definitive diagnosis of atypical teratoid rhabdoid tumor.[1]

Fluorescent In Situ Hybridization

Bone Marrow Aspiration

(Bone Marrow Asperant) to check for bone tumors. Often a doctor will want perform a stem cell transplant

References

  1. Diagnostic evaluation of atypical teratoid rhabdoid tumor. National Cancer Institute 2015. http://www.cancer.gov/types/brain/hp/child-cns-atrt-treatment-pdq#link/_113_toc. Accessed on December 16, 2015

Template:WH Template:WS